{"id":"W3021063182","doi":"10.1016/s0140-6736(03)14284-5","title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","year":2003,"lang":"en","type":"article","venue":"The Lancet","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1684,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"AstraZeneca","keywords":"Candesartan; Cardiology; Medicine; Heart failure; Internal medicine; Charm (quantum number); Angiotensin-converting enzyme; Angiotensin II; Blood pressure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}